Musculoskeletal Pain Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2021 To 2032
Musculoskeletal Pain conditions are
typically characterized by pain (often chronic pain) and limitations in
mobility, agility, and functional ability, reducing people's ability to work
and participate in social roles, with associated effects on mental wellbeing
and, on a broader level, effects on community prosperity. Osteoarthritis, back
and neck pain, fractures associated with bone fragility, injuries, and systemic
inflammatory conditions such as rheumatoid arthritis are the most common and
disabling musculoskeletal disorders. There is a need for a more comprehensive
approach to work retention and rehabilitation that considers the complex and
multifaceted nature of presenteeism, absenteeism, and long-term incapacity for
work. Chronic pain conditions affecting the musculoskeletal system often have
no cure, and people with these conditions are among the most affected by
disability in our community. Musculoskeletal pain is associated with musculoskeletal
(MSK) conditions that affect the muscles, bones, and joints. They are often,
but not always, associated with injury or old age. Painful MSK conditions
include arthritis, back pain, neck pain, shoulder pain, foot pain, and
osteoporosis. The most effective way to manage pain from MSK conditions is with
multidisciplinary pain management and self-management. In a few cases, the
condition may be improved with joint replacement surgery or a spinal cord
stimulator implantation by a specially trained pain specialist.
- The prevalence of Musculoskeletal pain ranges from 10 MN to
12 MN among 18 years and older population in the USA.
Thelansis’s “Musculoskeletal Pain Market
Outlook, Epidemiology, Competitive
Landscape, and Market Forecast Report – 2021 To 2032" covers disease
overview, epidemiology, drug utilization, prescription share analysis,
competitive landscape, clinical practice, regulatory landscape, patient share,
market uptake, market forecast, and key market insights under the potential Musculoskeletal
Pain treatment modalities options for eight major markets (USA, Germany,
France, Italy, Spain, UK, Japan, and China).
KOLs insights
of Musculoskeletal Pain across 8 MM market from the centre of Excellence/
Public/ Private hospitals participated in the study. Insights around current
treatment landscape, epidemiology, clinical characteristics, future treatment
paradigm, and Unmet needs.
Musculoskeletal Pain Market Forecast Patient
Based Forecast Model (MS. Excel Based Automated Dashboard), which Data Inputs
with sourcing, Market Event, and Product Event, Country specific Forecast
Model, Market uptake and patient share uptake, Attribute Analysis, Analog
Analysis, Disease burden, and pricing scenario, Summary, and Insights.
Thelansis Competitive Intelligence (CI) practice
has been established based on a deep understanding of the pharma/biotech
business environment to provide an optimized support system to all levels of
the decision-making process. It enables business leaders in forward-thinking
and proactive decision-making. Thelansis supports scientific and commercial
teams in seamless CI support by creating an AI/ ML-based technology-driven
platform that manages the data flow from primary and secondary sources.
Comments
Post a Comment